✦ LIBER ✦

The costs and benefits of regulations for reimbursement of new drugs

✍ Scribed by Jonas Lundkvist; Bengt Jönsson; Clas Rehnberg

Book ID: 116516547
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 215 KB
Volume: 79
Category: Article
ISSN: 0168-8510
DOI: 10.1016/j.healthpol.2006.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discounting the Benefits and Costs of En

Discounting the Benefits and Costs of Environmental Regulations

✍ Jeffrey A. Kolb and Joel D. Scheraga 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

On-Road Vehicle Emissions: Regulations,

On-Road Vehicle Emissions: Regulations, Costs, and Benefits

✍ Beaton, S. P.; Bishop, G. A.; Zhang, Y.; Stedman, D. H.; Ashbaugh, L. L.; Lawson 📂 Article 📅 1995 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 155 KB

Costs and Benefits of Resistance against

Costs and Benefits of Resistance against Antimalarial Drugs

✍ J.C Koella 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Benefits and costs of newer drugs: an up

Benefits and costs of newer drugs: an update

✍ Frank R. Lichtenberg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract In previous work, we found strong evidence to support the hypothesis that the replacement of older drugs by new drugs resulted in reductions in total medical expenditures. In this study, we update and extend our previous study of the effect of drug age—years since FDA approval—on total

Balancing the benefits and costs of anti

Balancing the benefits and costs of antibiotic drugs: the TREAT model

✍ L. Leibovici; M. Paul; S. Andreassen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

PHP156 Amnog – Summary of Outcomes of Ea

PHP156 Amnog – Summary of Outcomes of Early Benefit Assessment and Reimbursement Negotiation for New Drugs in Germany

✍ V. Claus; D. Freyer; W. Kotowa; J. Mathes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB